SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001802768-20-000010
Filing Date
2020-11-12
Accepted
2020-11-12 17:06:26
Documents
83
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rprx-20200930.htm   iXBRL 10-Q 2712439
2 EX-31.1 rprx-20200930ex311.htm EX-31.1 8706
3 EX-31.2 rprx-20200930ex312.htm EX-31.2 8743
4 EX-32 rprx-20200920ex32.htm EX-32 5401
  Complete submission text file 0001802768-20-000010.txt   11330861

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rprx-20200930.xsd EX-101.SCH 79653
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rprx-20200930_cal.xml EX-101.CAL 117632
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rprx-20200930_def.xml EX-101.DEF 510951
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rprx-20200930_lab.xml EX-101.LAB 860836
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rprx-20200930_pre.xml EX-101.PRE 617012
10 EXTRACTED XBRL INSTANCE DOCUMENT rprx-20200930_htm.xml XML 1971612
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39329 | Film No.: 201307876
SIC: 2834 Pharmaceutical Preparations